Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group With a Crossover Confirmation Period Study of RWJ-333369 for the Treatment of Postherpetic Neuralgia.

NCT00492323 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT00492323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00492323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group With a Crossover Confirmation Period Study of RWJ-333369 for the Treatment of Postherpetic Neuralgia.
Lead sponsor
SK Life Science, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
June 30, 2008
Enrollment
91 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, neuralgia, postherpetic neuralgia